US Patent Issued to Universitatsklinikum Regensburg on March 11 for "Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer" (German Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,973, issued on March 11, was assigned to Universitatsklinikum Regensburg (Regensburg, Germany).

"Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer" was invented by Edward Geissler (Regensburg, Germany), Maria Mycielska (Regensburg, Germany) and Petra Rummele (Regensburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to a method for the diagnosis of cancer involving the plasma membrane citrate transporter (pmCiC). The invention is further directed to a modified substrate or modulator of pmCiC, the use of pmCiC as a tumor marker and a method of screening for a modulator of ...